Privia Health Group is projected to report Q3 2026 revenue of $610.72 million and EPS of $0.09, with the current stock price of $21.48 trading at a significant discount to the $31.47 average analyst price target.
The key metric for this quarter is Total Practice Collections, as investors gauge the company's platform scale and its ability to capture a larger share of physician billings following recent market expansions.
Recent growth has been supported by the acquisition of American Choice Healthcare's MSSP business, though market sentiment remains focused on the pace of new provider implementations and attributed lives growth. Management’s guidance for the 2027 recruitment cycle will be critical for assessing long-term sustainability and operating leverage.